The Cystic Fibrosis Foundation teams up with Pfizer, one of the world's largest pharmaceutical companies, to find new therapies that tackle the root cause of CF in people with the Delta F508 mutation. Watch an interview with Ed Mascioli, M.D., vice president of the Orphan and Genetic Diseases Research Unit at Pfizer.
Link to this comment:
All Comments (0)